Skip to main content

Advertisement

SpringerLink
Log in

Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Adrenal tumors are a common manifestation of the multiple endocrine neoplasia type 1 (MEN-1) syndrome. Prevalence in recent studies varies between 9 and 45%. A genotype–phenotype correlation has been described as well as the development of adrenocortical carcinomas. Long-term prospective data are still lacking.

Materials and methods

Thirty-eight MEN-1 patients with proven germline mutations have been prospectively observed in a regular screening program in our hospital. Adrenal glands have been screened by biochemical analysis and either by endoscopic ultrasound (EUS) or computed tomography (CT) or both. Median follow-up was 48 months (12–108 months). Age at diagnosis of MEN-1, type of adrenal tumor, genotype, therapy, and clinical characteristics have been analyzed.

Results

In 21 (55%) patients, adrenal involvement of the disease was detected. Adrenal lesions were detected in average 6.9 years after the initial diagnosis of MEN-1. Median tumor size was 12 mm (5–40 mm). Tumor size smaller than 10 mm was observed in 11 patients. Twelve patients had unilateral while nine had bilateral adrenal lesions. EUS detected all adrenal tumors, whereas CT failed in seven cases. In three patients, functioning tumors (one pheochromocytoma, one bilateral Cushing adenoma, and one adrenocortical carcinoma) and one nonfunctioning adenoma were diagnosed by histology and biochemical assessment. Two laparoscopic adrenalectomies and one laparoscopic subtotal resection were performed. Nonfunctioning adrenal lesions, not characterized by histology yet, were found in 18 patients. There was no statistical difference with regard to adrenal involvement between patients with germline mutations in exons 2 and 10 (12/21) and those with mutations in exons 3–9 (6/11).

Conclusion

MEN-1-associated adrenal tumors are mostly small, benign, and nonfunctioning and much more common than previously reported. EUS was the most sensitive imaging procedure. The genotype–pheotype correlation previously suggested by our group could not be confirmed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Chandrasekharappa SC et al (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276(5311):404–407

    Article  PubMed  CAS  Google Scholar 

  2. Wermer P (1954) Genetic aspects of adenomatosis of endocrine glands. Am J Med 16:363–371

    Article  PubMed  CAS  Google Scholar 

  3. Burgess JR, Greenaway TM, Shepherd JJ (1998) Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med 243(6):465–470

    Article  PubMed  CAS  Google Scholar 

  4. Darling TN et al (1997) Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 133(7):853–857

    Article  PubMed  CAS  Google Scholar 

  5. Duh QY et al (1987) Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 154(1):142–148

    Article  PubMed  CAS  Google Scholar 

  6. Gibril F et al (2003) Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 88(3):1066–1081

    Article  PubMed  CAS  Google Scholar 

  7. Hofmann M et al (1998) Multiple endocrine neoplasia associated with multiple lipomas. Med Klin (Munich) 93(9):546–549

    Article  CAS  Google Scholar 

  8. Marx S et al (1998) Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129(6):484–494

    PubMed  CAS  Google Scholar 

  9. Lips CJ, Vasen HF, Lamers CB (1984) Multiple endocrine neoplasia syndromes. Crit Rev Oncol Hematol 2(2):117–184

    PubMed  CAS  Google Scholar 

  10. Thakker RV (2000) Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 29(3):541–567

    Article  PubMed  CAS  Google Scholar 

  11. Carty SE et al (1998) The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124(6):1106–1113; discussion 1113–4

    Article  PubMed  CAS  Google Scholar 

  12. Skogseid B et al (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 75(1):76–81

    Article  PubMed  CAS  Google Scholar 

  13. Skogseid B et al (1995) Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118(6):1077–1082

    Article  PubMed  CAS  Google Scholar 

  14. Burgess JR et al (1996) Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg 131(7):699–702

    PubMed  CAS  Google Scholar 

  15. Langer P et al (2002) Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg 26(8):891–896

    Article  PubMed  Google Scholar 

  16. Barzon L et al (2001) Multiple endocrine neoplasia type 1 and adrenal lesions. J Urol 166(1):24–27

    Article  PubMed  CAS  Google Scholar 

  17. Gibril F et al (2004) Multiple endocrine neoplasia type 1 and Zollinger–Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) 83(1):43–83

    Article  Google Scholar 

  18. Cadiot G et al (1999) Prognostic factors in patients with Zollinger–Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d’Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d’Etude du Syndrome de Zollinger–Ellison (GRESZE). Gastroenterology 116(2):286–293

    Article  PubMed  CAS  Google Scholar 

  19. Ballard HS, Fame B, Hartstock RJ (1964) Familial endocrine adenoma-peptic ulcer complex. Medicine (Baltimore) 43:481–516

    Article  CAS  Google Scholar 

  20. Croisier JC, Azerad E, Lubetzki J (1971) L’adenomatose polyendocrinienne (syndrome de Wermer). Semin Hop Paris 47:494–525

    CAS  Google Scholar 

  21. Dobbie JW (1969) Adrenocortical nodular hyperplasia: the ageing adrenal. J Pathol 99:1–18

    Article  PubMed  CAS  Google Scholar 

  22. Kokko JP, Brown TC, Berman MM (1967) Adrenal adenoma and hypertension. Lancet 1(7488):468–470

    Article  PubMed  CAS  Google Scholar 

  23. Hedeland H, Ostberg G, Hokfelt B (1968) On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184(3):211–214

    PubMed  CAS  Google Scholar 

  24. Anonymous (2002) NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens State Sci Statements 19(2):1–25

    Google Scholar 

  25. Thompson GB, Young WF Jr (2003) Adrenal incidentaloma. Curr Opin Oncol 15(1):84–90

    Article  Google Scholar 

  26. Kloos RT et al (1997) Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I-6beta-iodomethyl-norcholesterol scintigraphy. World J Surg 21(1):36–40

    Article  PubMed  CAS  Google Scholar 

  27. Commons RR, Callaway CP (1948) Adenomas of the adrenal cortex. Arch Intern Med 81:37–41

    CAS  Google Scholar 

  28. Reinhard C, Saeger W, Schubert B (1996) Adrenocortical nodules in post-mortem series. Development, functional significance, and differentiation from adenomas. Gen Diagn Pathol 141(3–4):203–208

    PubMed  CAS  Google Scholar 

  29. Granger P, Genest J (1970) Autopsy study of adrenals in unselected normotensive and hypertensive patients. Can Med Assoc J 103(1):34–36

    PubMed  CAS  Google Scholar 

  30. Brandi ML et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86(12):5658–5671

    Article  PubMed  CAS  Google Scholar 

  31. Skogseid B et al (1996) Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg 20(7):872–876; discussion 877

    Article  PubMed  CAS  Google Scholar 

  32. Brandi ML et al (1987) Familial multiple endocrine neoplasia type I: a new look at pathophysiology. Endocr Rev 8(4):391–405

    Article  PubMed  CAS  Google Scholar 

  33. Trump D et al (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med 89(9):653–669

    CAS  Google Scholar 

  34. Chico A et al (2000) Genetic, clinical, and biochemical analysis of unrelated Spanish families with multiple endocrine neoplasia type I. Endocr Pract 6(1):13–19

    PubMed  CAS  Google Scholar 

  35. Agarwal SK et al (1999) Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96(1):143–152

    Article  PubMed  CAS  Google Scholar 

  36. Kim YS et al (1999) Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene 18(43):5936–5942

    Article  PubMed  CAS  Google Scholar 

  37. Heppner C et al (2001) The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 20(36):4917–4925

    Article  PubMed  CAS  Google Scholar 

  38. Zwermann O et al (2000) Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors. Eur J Endocrinol 142(6):689–695

    Article  PubMed  CAS  Google Scholar 

  39. Schulte KM et al (1999) MEN I gene mutations in sporadic adrenal adenomas. Hum Genet 105(6):603–610

    Article  PubMed  CAS  Google Scholar 

  40. Gortz B et al (1999) MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer 80(3):373–379

    Article  PubMed  CAS  Google Scholar 

  41. Heppner C et al (1999) MEN1 gene analysis in sporadic adrenocortical neoplasms. J Clin Endocrinol Metab 84(1):216–219

    Article  PubMed  CAS  Google Scholar 

  42. Crabtree JS et al (2001) A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 98(3):1118–1123

    Article  PubMed  CAS  Google Scholar 

  43. Tomassetti P et al (1995) Chromosomal instability in multiple endocrine neoplasia type 1. Cytogenetic evaluation with DEB test. Cancer Genet Cytogenet 79(2):123–126

    Article  PubMed  CAS  Google Scholar 

  44. Scappaticci S et al (1992) Cytogenetics of multiple endocrine neoplasia syndrome. II. Chromosome abnormalities in an insulinoma and a glucagonoma from two subjects with MEN1. Cancer Genet Cytogenet 63(1):17–21

    Article  PubMed  CAS  Google Scholar 

  45. Pannett AA, Thakker RV (2001) Somatic mutations in MEN type 1 tumors, consistent with the Knudson “two-hit” hypothesis. J Clin Endocrinol Metab 86(9):4371–4374

    Article  PubMed  CAS  Google Scholar 

  46. Bartsch DK et al (2000) Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 128(6):958–966

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Philipps-University, Marburg, Germany

    J. Waldmann, V. Fendrich, M. Rothmund & P. Langer

  2. Department of Surgery, Städtische Kliniken Bielefeld, Bielefeld, Germany

    D. K. Bartsch

  3. Division of Endocrinology and Diabetology, Philipps-University, Marburg, Germany

    P. H. Kann

  4. Department of Surgery, Philipps-University Hospital, Baldingerstrasse, 35033, Marburg, Germany

    P. Langer

Authors
  1. J. Waldmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. K. Bartsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. H. Kann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. Fendrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Rothmund
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Langer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Langer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waldmann, J., Bartsch, D.K., Kann, P.H. et al. Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening. Langenbecks Arch Surg 392, 437–443 (2007). https://doi.org/10.1007/s00423-006-0124-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-006-0124-7

Keywords

Search

Navigation